Annotation Detail for ARAP3

 Basic Information 
Top
        	
        			| Pathway ID | Pathway Name | 
|---|
| hsa04144 | Endocytosis | 
| Pathway ID | Pathway Name | 
|---|
|  | Signaling by Rho GTPases | 
| Pathway ID | Pathway Name | 
|---|
| 200098 | Class I PI3K signaling events | 
| 200050 | Regulation of RhoA activity | 
 
        	
        			| Desease ID | Desease Name | 
|---|
| 2087 | Bacterial infection | 
 
        	
        			| Chemical ID | Chemical Name | Interaction | Interaction Action | Publication | 
|---|
| D004958 | Estradiol | [Progesterone co-treated with Estradiol] results in decreased expression of ARAP3 mRNA | affects cotreatment|decreases expression | 17404688 
 | 
| D011374 | Progesterone | [Progesterone co-treated with Estradiol] results in decreased expression of ARAP3 mRNA | affects cotreatment|decreases expression | 17404688 
 | 
| Disease ID | Disease Name | Direct Evidence | Inference Chemical Name | Inference Score | Publication | 
|---|
| MESH:D000230 | Adenocarcinoma |  | Estradiol | 2.18 | 11473722 | 
| MESH:D020201 | Brain Hemorrhage, Traumatic |  | Progesterone | 6.41 | 17868700 | 
| MESH:D001930 | Brain Injuries |  | Progesterone | 5.02 | 15665606	15845082	15380490 | 
| MESH:D001943 | Breast Neoplasms |  | Estradiol | 2.17 | 16675129	17261762	12948864	18497071	17289903	19861407	17018787	14630087 | 
| MESH:D001943 | Breast Neoplasms |  | Progesterone | 2.17 | 17614352	15562024	16175315 | 
| MESH:D002181 | Candidiasis, Vulvovaginal |  | Estradiol | 5.35 | 16111702 | 
| MESH:D006528 | Carcinoma, Hepatocellular |  | Estradiol | 1.80 | 16924424 | 
| MESH:D002471 | Cell Transformation, Neoplastic |  | Estradiol | 3.09 | 18566989 | 
| MESH:D003928 | Diabetic Nephropathies |  | Estradiol | 3.88 | 19279558 | 
| MESH:D003929 | Diabetic Neuropathies |  | Progesterone | 5.26 | 17187935 | 
| MESH:D004681 | Encephalomyelitis, Autoimmune, Experimental |  | Progesterone | 4.45 | 17692515 | 
| MESH:D016889 | Endometrial Neoplasms |  | Estradiol | 3.28 | 19148513	11473722	18566989 | 
| MESH:D004715 | Endometriosis |  | Progesterone | 4.27 | 16134523 | 
| MESH:D006558 | Herpes Genitalis |  | Estradiol | 6.10 | 15709030 | 
| MESH:D019584 | Hot Flashes |  | Estradiol | 4.82 | 17088409 | 
| MESH:D020244 | Infarction, Middle Cerebral Artery |  | Progesterone | 5.17 | 15869954 | 
| MESH:D007249 | Inflammation |  | Progesterone | 2.81 | 15869954 | 
| MESH:D007333 | Insulin Resistance |  | Estradiol | 3.26 | 16393666	16627594 | 
| MESH:D007674 | Kidney Diseases |  | Estradiol | 2.83 | 15618244 | 
| MESH:D007680 | Kidney Neoplasms |  | Estradiol | 3.41 | 15610895 | 
| MESH:D008106 | Liver Cirrhosis, Experimental |  | Estradiol | 1.69 | 14659978	14716833 | 
| MESH:D008325 | Mammary Neoplasms, Experimental |  | Estradiol | 7.04 | 11807958	16891317	17203775	11408345 | 
| MESH:D008325 | Mammary Neoplasms, Experimental |  | Progesterone | 7.04 | 17203775	11408345 | 
| MESH:D020149 | Manganese Poisoning |  | Estradiol | 5.55 | 19453300 | 
| MESH:D015428 | Myocardial Reperfusion Injury |  | Estradiol | 3.66 | 16810080 | 
| MESH:D009389 | Neovascularization, Pathologic |  | Estradiol | 4.62 | 17289903 | 
| MESH:D009421 | Nervous System Malformations |  | Estradiol | 4.32 | 16427766	11399458 | 
| MESH:D010051 | Ovarian Neoplasms |  | Estradiol | 5.26 | 19401270 | 
| MESH:D010051 | Ovarian Neoplasms |  | Progesterone | 5.26 | 17393432	16525653 | 
| MESH:D019048 | Prostatic Intraepithelial Neoplasia |  | Estradiol | 4.44 | 20887781 | 
| MESH:D011471 | Prostatic Neoplasms |  | Estradiol | 3.01 | 16740699 | 
| MESH:D012468 | Salivary Gland Neoplasms |  | Progesterone | 2.98 | 18045962 | 
| MESH:D013119 | Spinal Cord Injuries |  | Progesterone | 5.17 | 15862959	16503802 | 
| MESH:D013978 | Tibial Fractures |  | Estradiol | 5.76 | 19048282 |